00:00-00:07
[OPEN ON JULIA RUNNING IN THE PARK AND LAURA RIDING HER BIKE IN A PARK]
JULIA: Hi, I’m Julia.
LAURA: I’m Laura and I’m on the move.
JULIA: I’m on the move.
CAPTION: Julia and Laura are real adult patients taking Mounjaro (tirzepatide). They were compensated for their time.
00:07-00:24
[Laura riding bike in background. Intro sequence with Mounjaro logo appears. A timer starts counting down till Laura and Julia’s story starts, beginning from 54 seconds.]
CAPTION: once weekly
mounjaro®
(tirzepatide) injection
Mounjaro® (mown-JAHR-OH) is an injectable medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
Laura and Julia's story will continue in 54 seconds
00:24-00:51
[Wide shot of park scenery stays in the background while the select safety information with warning appears on the screen.]
CAPTION: once weekly
mounjaro®
(tirzepatide) injection
Laura and Julia's story will continue in 37 seconds
Select Safety Information
Warning:
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
00:51-01:02
[Wide shot of park bridge with Julia approaching. Safety information continues.]
CAPTION:
once weekly
mounjaro®
(tirzepatide) injection
Laura and Julia's story will continue in 11 seconds
Select Safety Information
Warning:
Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
See Indication and Safety Summary with Warnings at the end of this video.
01:02-01:08
[Julia, sitting in living room, talking to the camera]
JULIA: When it was time for my first injection, I can remember pulling the pen out of the box and…
CAPTION: Julia is a real adult patient taking Mounjaro for type 2 diabetes.
01:08-01:12
[Julia, sitting in living room, talking to the camera]
JULIA: …oh, my gosh, I’m gonna cry. Why am I gonna cry?
01:12-01:14
[Close-up on Laura, talking to the camera]
LAURA: I was super excited to start it...
CAPTION: Laura is a real adult patient taking Mounjaro for type 2 diabetes. She was compensated for her time.
01:14-01:17
[Laura, sitting in living room, talking to the camera]
LAURA: And to see how that was gonna work for me.
CAPTION: Laura is a real adult patient taking Mounjaro for type 2 diabetes. She was compensated for her time.
01:17-01:27
[Julia sitting in living room talking to camera]
JULIA: And that first click …felt like somebody was, like… yes, girl, we’re going. We’re going on this journey together. And it’s gonna be incredible.
CAPTION: Individual results may vary.
01:27-01:29
[Julia, sitting on the couch, looking at her sneakers]
JULIA: Ever since then, every time I…
01:29-01:31
[Close-up of Julia’s running shoes]
JULIA: …go get my pen, like…
01:31-01:32
[Julia, getting up from the couch]
JULIA: …it was my own little cheerleading section.
CAPTION: Up to 90% of adults taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C<7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses.
In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
01:32-01:34
[Julia fastens her fanny pack]
JULIA: Ready to go!
CAPTION: Up to 90% of adults taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C<7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses.
In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
01:34-01:36
[Close-up of Laura taking a picture with her camera]
LAURA: Taking Mounjaro…
CAPTION: Up to 90% of adults taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C<7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses.
In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
01:36-01:38
[Laura, meal prepping in kitchen]
LAURA: …along with diet and exercise…
CAPTION: Up to 90% of adults taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C<7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses.
In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
01:38-01:41
[Laura cutting tomatoes]
LAURA: …and seeing my A1C go below a 7 and…
CAPTION: Up to 90% of adults taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C<7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses.
In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
01:41-01:45
[Laura, placing tomatoes into a container]
LAURA: …losing some weight really motivated me to continue on…
CAPTION: Adults taking Mounjaro lost up to 25 lb.
Mounjaro is not a weight loss drug.
Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5mg) to 25 lb (15 mg).
01:45-01:47
[Close-up of Laura tasting her food]
LAURA: …my journey with the medication.
CAPTION: Adults taking Mounjaro lost up to 25 lb.
Mounjaro is not a weight loss drug.
Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5mg) to 25 lb (15 mg).
01:47-01:49
[Laura sitting in the living room talking to the camera]
LAURA: The more physical you become, the better you wanna eat.
CAPTION: Mounjaro is a prescription medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
01:49-01:50
[Laura seasoning her food]
LAURA: So, as part of my diet…
CAPTION: Mounjaro is a prescription medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
01:50-01:52
[Laura closing food container]
LAURA: I find myself cooking at home more. Having…
CAPTION: Mounjaro is a prescription medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
01:52-01:56
[Close-up of Laura gathering her things]
LAURA: …less carbs, more chicken, more fish.
01:56-01:59
[Julia, live recording on her phone]
JULIA: We’re getting ready to hit the trail this morning.
JULIA: Eating smaller meals…
01:59-02:00
[Shot of Julia’s food and drink]
JULIA: …and eating more frequently…
02:00-02:01
[Shot from above of Julia’s yogurt]
JULIA: …helped me.
02:01-02:04
[Shot from above of Julia adding raspberries to yogurt. Julia sitting in the living room talking to the camera.]
JULIA: The Mounjaro pen is easy to use. And…
CAPTION: Mounjaro comes in an easy-to-use single-dose pen.*
*Before using the Mounjaro Pen, read the Instructions for Use (IFU). In a study of adults with type 2 diabetes for another medicine that uses the same single-dose pen as Mounjaro, 99% said that, after adequate training, the single-dose pen was easy to use. The IFU for the Mounjaro single-dose pen differ from the IFU provided in the study.
02:04-02:11
[Above shot of Julia’s feet in her running shoes. Julia, walking towards the door and walking out of it.]
JULIA: …that’s great because I’m always on the go, so it fits in really nicely with my lifestyle. It’s just part of my routine, now. Like brushing my teeth.
CAPTION: Mounjaro comes in an easy-to-use single-dose pen.*
*Before using the Mounjaro Pen, read the Instructions for Use (IFU). In a study of adults with type 2 diabetes for another medicine that uses the same single-dose pen as Mounjaro, 99% said that, after adequate training, the single-dose pen was easy to use. The IFU for the Mounjaro single-dose pen differ from the IFU provided in the study.
02:11-02:17
[Laura walking toward her bike and grabbing her helmet.]
LAURA: I have my routine of taking my Mounjaro every Monday morning. I don’t have to…
CAPTION: Mounjaro is designed to be used once a week.
Store your pen in the refrigerator and make sure the temperature is between 36°F to 42°F.
When not refrigerated, Mounjaro can be stored at room temperature for up to 21 days. Store it in its original carton to protect from light.
02:17-02:22
[Close-up of Laura, talking to the camera. Cuts to show Laura putting on her helmet.]
LAURA: …worry about missing a dose because it’s always with me, no matter where I go.
CAPTION: If you miss a dose of Mounjaro, take the missed dose as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Do not take 2 doses of Mounjaro within 3 days of each other.
02:22-02:32
[Back and forth shots of Julia, power-walking on the park bridge and speaking to the camera.]
JULIA: I was always an avid runner. Seeing the progress that I was starting to make, it really helped me be motivated to pick it up a little bit every day. …
02:32-02:38
[Julia, sitting in the living room, talking to the camera. Shots of Julia walking on rocky terrain and running on the park bridge.]
JULIA: Very slow walks turned into brisk speed-walking, and now I’m back to running.
02:38-02:45
[Laura, riding a bike through the park. Close-up of Laura, talking to the camera]
LAURA: I got out of my comfort zone and took a belly dancing class and I really wanna join a Zumba class.
02:45-02:52
[Laura, riding a bike through the park]
LAURA: Because my A1C is lower, I’m motivated to adventure out and do things that I haven’t done.
CAPTION: Mounjaro is proven to lower A1C.*
In adults with type 2 diabetes.
*Along with diet and exercise.
02:52-03:01
[Close-up of Julia, drinking from water bottle and stretching in the park. Close-up of Julia, sitting in the living room, talking to the camera.]
JULIA: What on the move means to me now? Moving my body and trying fun things. It also means that I am on the move with the people around me.
03:01-03:07
[Mobile phone showing different photos of Julia going on charity races]
JULIA: I’m in my second year of planning a 5k for our community. It’s work that I’m so proud of.
03:07-03:15
[Laura, sitting in the living room, talking to the camera. Mobile phone showing different photos of Laura traveling with her mom.]
LAURA: I’m traveling with my mom. I’ve gone to Egypt, the Netherlands, Belgium. I have a list of places I’ve been and places I’m going.
03:15-03:18
[Mobile phone, showing Laura on the back of a motorcycle, waving bye as she rides away]
LAURA: I go on charity motorcycle rides.
03:18-03:30
[Julia, standing on park bridge, looking out. Close-up of Julia, talking to the camera. Close-up of Julia, talking to the camera.]
JULIA: Having my A1C lowered really helps me feel empowered to work on maintaining my progress. It’s really given me the confidence and the power back to myself.
CAPTION: Up to 90% of adults taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C<7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses.
In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
03:30-03:40
[Laura walking her bike and taking pictures. Laura speaking to the camera.]
LAURA: It compels me and motivates me to be able to get out and do the things that I love and I can, once again, enjoy my passions and refinding myself.
03:40-03:45
[Split screen of close-up shot of Laura and Julia. Split screen of full-body shot of Laura and Julia.]
LAURA: I am not looking back.
JULIA: I’m on the move.
03:45-03:48
CAPTION: Talk to your doctor about once-weekly Mounjaro
Once Weekly
Mounjaro
(tirzepatide) injection
A Lilly Medicine
CAPTION: For more details and pricing information, visit Mounjaro.Lilly.com or call 1-800-545-5979 (1-800-LillyRX).
The Mounjaro logo, Mounjaro®, and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
03:48-11:22
[CBS animates full screen and begins scrolling]
Caption: once weekly
mounjaro®
(tirzepatide) injection
Caption: INDICATION AND SAFETY SUMMARY WITH WARNINGS
Mounjaro® (mown-JAHR-OH) is an injectable medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
- It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
Warnings - Mounjaro may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
- Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
- Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.
Mounjaro may cause serious side effects, including:
Inflammation of the pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back.
Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
Dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.
Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.
Gallbladder problems. Gallbladder problems have happened in some people who use Mounjaro. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.
Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Mounjaro may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Mounjaro before you are scheduled to have surgery or other procedures.
Common side effects
The most common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Mounjaro. Talk to your healthcare provider about any side effect that bothers you or doesn't go away.
Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before using Mounjaro
- Your healthcare provider should show you how to use Mounjaro before you use it for the first time.
- Talk to your healthcare provider about low blood sugar and how to manage it.
- If you take birth control pills by mouth, talk to your healthcare provider before you use Mounjaro. Birth control pills may not work as well while using Mounjaro. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Mounjaro and for 4 weeks after each increase in your dose of Mounjaro.
Review these questions with your healthcare provider:
- Do you have other medical conditions, including problems with your pancreas, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
- Do you take other diabetes medicines, such as insulin or sulfonylureas?
- Do you have a history of diabetic retinopathy?
- Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)?
- Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? It is not known if Mounjaro will harm your unborn baby. Mounjaro may pass into your breast milk.
- Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
How to take
- Read the Instructions for Use that come with Mounjaro.
- Use Mounjaro exactly as your healthcare provider says.
- A caregiver may give you Mounjaro injections, or you may self-inject if a healthcare provider determines that it is appropriate.
- Inject Mounjaro under the skin (subcutaneously) of your stomach (abdomen), thigh, or another person should inject in the back of the upper arm. Do not inject Mounjaro into a muscle (intramuscularly) or vein (intravenously).
- Use Mounjaro 1 time each week, at any time of the day.
- Do not mix insulin and Mounjaro together in the same injection.
- You may give an injection of Mounjaro and insulin in the same body area (such as your stomach area), but not right next to each other.
- Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
- If you take too much Mounjaro, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Learn more
Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection. For more information, call 1-800-LillyRX (800-545-5979) or go to www.mounjaro.lilly.com.
This summary provides basic information about Mounjaro but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Mounjaro and how to take it. Your healthcare provider is the best person to help you decide if Mounjaro is right for you.
TR CON BS 19DEC2025
Some voice over generated by Al.
The Mounjaro logo, Mounjaro®, and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
11:22-11:28
[Mounjaro end card appears with trademark information.]
CAPTION: Once weekly
Mounjaro
(tirzepatide) injection
A Lilly Medicine
Lilly
A Medicine Company
CAPTION: The Mounjaro logo, Mounjaro®, and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
CMAT-11324 02/2026 ©Lilly USA, LLC 2026. All rights reserved.